Preanalytical standardization of amino acid and acylcarnitine metabolite profiling in human blood using tandem mass spectrometry

Metabolomics

Volumn 7, Issue 3, 2011, Pages 344-352

  Brauer, Romy ^a   Leichtle, Alexander Benedikt ^a   Fiedler, Georg Martin ^a   Thiery, Joachim ^a   Ceglarek, Uta ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Acylcarnitines; Amino acids; Dried blood; Metabolite profiling; Preanalytical standardization

Indexed keywords

ACYLCARNITINE; AMINO ACID; ANTICOAGULANT AGENT; EDETIC ACID; LONG CHAIN FATTY ACID; SHORT CHAIN FATTY ACID;

ADULT; AMINO ACID ANALYSIS; AMINO ACID BLOOD LEVEL; AMINO ACID COMPOSITION; ARTICLE; BLOOD ANALYSIS; BLOOD FILTER; CAPILLARY BLOOD; CLINICAL PROTOCOL; CONTROLLED STUDY; DIET RESTRICTION; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; IN VIVO STUDY; INTERMETHOD COMPARISON; LIPID BLOOD LEVEL; MALE; METABOLITE; NUTRITIONAL STATUS; PHYSICAL ACTIVITY; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; STANDARDIZATION; TANDEM MASS SPECTROMETRY; VENOUS BLOOD;

EID: 80051669357     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-010-0256-1     Document Type: Article

References (36)

1. Arn, P. H. (2007). Newborn screening: Current status. Health Affairs (Millwood), 26, 559.
2. Blau, N. D., Duran, M., Blaskovics, M. E., & Gibson, K. M. (2003). Physician's guide to the laboratory diagnosis of metabolic diseases. Heidelberg: Springer.
3. Bremer, H. J., Duran, M., Kamerling, J. P., Przyrembel, H., & Wadman, S. K. (1981). Disturbances of Amino Acid Metabolism: Clinical Chemistry and Diagnosis. München: Urban & Schwarzberg.
4. Bruce, S. J., Jonsson, P., Antti, H., Cloarec, O., Trygg, J., Marklund, S. L., et al. (2008). Evaluation of a protocol for metabolic profiling studies on human blood plasma by combined ultra-performance liquid chromatography/mass spectrometry: From extraction to data analysis. Analytical Biochemistry, 372, 237.
5. Ceglarek, U., Leichtle, A., Brugel, M., Kortz, L., Brauer, R., Bresler, K., et al. (2009). Challenges and developments in tandem mass spectrometry based clinical metabolomics. Molecular and Cellular Endocrinology, 301, 266.
6. Ceglarek, U., Muller, P., Stach, B., Buhrdel, P., Thiery, J., & Kiess, W. (2002). Validation of the phenylalanine/tyrosine ratio determined by tandem mass spectrometry: Sensitive newborn screening for phenylketonuria. Clinical Chemistry and Laboratory Medicine, 40, 693.
7. Chace, D. H., Hillman, S. L., van Hove, J. L., & Naylor, E. W. (1997). Rapid diagnosis of MCAD deficiency: Quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. Clinical Chemistry, 43, 2106.
8. Chace, D. H., & Kalas, T. A. (2005). A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. Clinical Biochemistry, 38, 296.
9. De Jesus, V. R., Chace, D. H., Lim, T. H., Mei, J. V., & Hannon, W. H. (2010). Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry. Clinica Chimica Acta, 411, 684.
10. Dunn, W. B. (2008). Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes. Physical Biology, 5, 11001.
11. Fahy, E., Sud, M., Cotter, D., & Subramaniam, S. (2007). LIPID MAPS online tools for lipid research. Nucleic Acids Research, 35, W606.
12. Fiedler, G. M., & Thiery, J. (2004). The incorrect laboratory result. Part 1: Pre- and postanalytical phase. Internist (Berl), 45, 315.
13. Foster, D. W. (2004). The role of the carnitine system in human metabolism. Annals of the New York Academy of Sciences, 1033, 1.
14. Gika, H. G., Theodoridis, G. A., & Wilson, I. D. (2008). Liquid chromatography and ultra-performance liquid chromatography-mass spectrometry fingerprinting of human urine: Sample stability under different handling and storage conditions for metabonomics studies. Journal of Chromatography. A, 1189, 314.
15. Guder, W., Narayanan, S., & Wisser, H. (1996). Samples: From the patient to the laboratory: The impact of preanalytical variables on the quality of laboratory results. Darmstadt: GIT Verlag.
16. Hall, R. D. (2006). Plant metabolomics: From holistic hope, to hype, to hot topic. New Phytologist, 169, 453.
17. Holub, M., Tuschl, K., Ratschmann, R., Strnadova, K. A., Muhl, A., Heinze, G., et al. (2006). Influence of hematocrit and localisation of punch in dried blood spots on levels of amino acids and acylcarnitines measured by tandem mass spectrometry. Clinica Chimica Acta, 373, 27.
18. Illig, T., Gieger, C., Zhai, G., Romisch-Margl, W., Wang-Sattler, R., Prehn, C., et al. (2010). A genome-wide perspective of genetic variation in human metabolism. Nature Genetics, 42, 137.
19. Jogl, G., Hsiao, Y. S., & Tong, L. (2004). Structure and function of carnitine acyltransferases. Annals of the New York Academy of Sciences, 1033, 17.
20. Johnson, C. A., & Bergeim, O. (1951). The distribution of free amino acids between erythrocytes and plasma in man. Journal of Biological Chemistry, 188, 833.
21. Leichtle, A. B., Ceglarek, U., Witzigmann, H., Gabel, G., Thiery, J., & Fiedler, G. M. (2010). Potential of dried blood self-sampling for cyclosporine c(2) monitoring in transplant outpatients. Journal of Transplantation, 2010, 201918.
22. Lv, Y., Liu, X., Yan, S., Liang, X., Yang, Y., Dai, W., et al. (2010). Metabolomic study of myocardial ischemia and intervention effects of Compound Danshen Tablets in rats using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 52, 129.
23. Mashego, M. R., Rumbold, K., De Mey, M., Vandamme, E., Soetaert, W., & Heijnen, J. J. (2007). Microbial metabolomics: Past, present and future methodologies. Biotechnological Letters, 29, 1.
24. Michopoulos, F., Theodoridis, G. A., Smith, C., & Wilson, I. D. (2010). Metabolite profiles from dried biofluid spots for metabonomic studies using UPLC Combined with oaToF-MS. Journal of Proteomic Research.
25. Morris, C. R. (2009). Asthma management: Reinventing the wheel in sickle cell disease. American Journal of Hematology, 84, 234.
26. Mueller, P., Schulze, A., Schindler, I., Ethofer, T., Buehrdel, P., & Ceglarek, U. (2003). Validation of an ESI-MS/MS screening method for acylcarnitine profiling in urine specimens of neonates, children, adolescents and adults. Clinica Chimica Acta, 327, 47.
27. Narayanan, S. (2000). The preanalytic phase-an important component of laboratory medicine. American Journal of Clinical Pathology, 113, 429.
28. Omodeo-Sale, F., Cortelezzi, L., Vommaro, Z., Scaccabarozzi, D., & Dondorp, A. M. (2010). Dysregulation of l-arginine metabolism and bioavailability associated to free plasma heme. The American Journal of Physiology-Cell Physiology, 299, C148.
29. Rashed, M. S., Ozand, P. T., Bucknall, M. P., & Little, D. (1995). Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatric Research, 38, 324.
30. Ronnett, G. V., Kim, E. K., Landree, L. E., & Tu, Y. (2005). Fatty acid metabolism as a target for obesity treatment. Physiology & Behavior, 85, 25.
31. Seeger, K. (2009). Metabolic changes in autoimmune diseases. Current Drug Discovery Technologies, 6, 256.
32. Wilcken, B. (2007). Recent advances in newborn screening. Journal of Inherited Metabolic Disease, 30, 129.
33. Wilcken, B., & Wiley, V. (2008). Newborn screening. Pathology, 40, 104.
34. Zhao, X., Fritsche, J., Wang, J., Chen, J., Rittig, K., Schmitt-Kopplin, P., et al. (2010). Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits. Metabolomics, 6, 362.
35. Zivkovic, A. M., Wiest, M. M., Nguyen, U. T., Davis, R., Watkins, S. M., & German, J. B. (2009a). Effects of sample handling and storage on quantitative lipid analysis in human serum. Metabolomics, 5, 507.
36. Zivkovic, A. M., Wiest, M. M., Nguyen, U., Nording, M. L., Watkins, S. M., & German, J. B. (2009b). Assessing individual metabolic responsiveness to a lipid challenge using a targeted metabolomic approach. Metabolomics, 5, 209.